Accessibility Menu
Blonder Tongue Laboratories logo

Blonder Tongue Laboratories(OTC) BDRL

Market CapN/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (1995)-100%
5 Year-100%
1 Year-99%
1 Month+100%
N/A
Blonder Tongue Laboratories last closing stock price
MetricPriceDate
Last closeUSD 0.002026-07-31
Blonder Tongue Laboratories stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+0%USD 0.002026-07-21
1 month+100%USD 0.002026-06-30
3 month-95%USD 0.002026-05-01
Year to date-97.98%USD 0.012025-12-31
1 year-99.33%USD 0.032025-07-31
3 year-99.89%USD 0.182023-08-01
5 year-99.98%USD 1.192021-07-30
Since inception-100%USD 9.881995-12-14

Blonder Tongue Laboratories Financials at a Glance

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$11.44M

Net Income (TTM)

-$1.32M

EPS (TTM)

N/A

P/E Ratio

N/A

Dividend

N/A

Beta (Volatility)

N/A

Price

N/A

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

Estimated Earnings Date

Jun 3, 2025

BDRL News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Blonder Tongue Laboratories

Blonder Tongue Laboratories, Inc. is a prominent developer and producer of advanced technology for television and broadband communication systems. Established in 1950 and based in Old Bridge, New Jersey, the company specializes in delivering comprehensive solutions for signal encoding, transcoding, and broadband products across the United States.

Products and Services
  • Advanced encoders and transcoders supporting various video resolutions
  • IP-based processing and headend equipment for IPTV format conversions
  • Customer premises equipment, including Android-powered IPTV set-top boxes
Growth Outlook
  • Recent quarterly revenue of $2.919 million shows stable demand
  • Gross profit margin improved to 34.5% in Q1 2025
  • Investment in R&D indicates commitment to innovation and market expansion
Financial Highlights
  • Trailing twelve months (TTM) revenue of $11.5 million reflects consistent performance
  • Operating cash flow of $661,000 in Q2 2024 demonstrates operational efficiency
  • Net income for Q1 2025 was -$314,000, indicating ongoing challenges
Blonder Tongue Laboratories, Inc. operates in the communication equipment industry, focusing on advanced technology solutions for television and broadband systems. The company’s diverse product offerings cater to a wide range of customer needs, from high-definition video encoding to broadband distribution. Recent financial performance indicates a stable revenue stream, with a notable gross profit margin improvement in the latest quarter. Despite facing challenges reflected in net income figures, the company’s commitment to research and development suggests a proactive approach to innovation and market growth. Investors may find the company’s strategic focus on technology and customer solutions appealing as it navigates the evolving landscape of communication equipment.
AI Generated • Jul 22, 2026

Industry

Communications Equipment

Sector

Information Technology

Employees

67

CEO

Robert J. Pallé, Jr.

Website

www.blondertongue.com

Headquarters

Old Bridge, NJ 08857, US

BDRL Financials

Key Financial Metrics (TTM)

Gross Margin

33.18%

Operating Margin

-6.11%

Net Income Margin

-11.18%

Return on Equity

110.79%

Return on Capital

-10.64%

Return on Assets

-13.24%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

N/A

Volume

N/A

Avg. Volume

N/A

Financials (TTM)

Gross Profit

$3.66M

Operating Income

-$763.00K

EBITDA

$377.00K

Operating Cash Flow

$1.09M

Capital Expenditure

-$89.00K

Free Cash Flow

$1.00M

Cash & ST Invst.

$93.00K

Total Debt

$8.17M

Blonder Tongue Laboratories Performance Analysis

Blonder Tongue Laboratories annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20212021-12-31USD 15,754,000N/A
20222022-12-31USD 18,115,00015.0%
20232023-12-31USD 13,213,000-27.1%
20242024-12-31USD 11,165,000-15.5%
Blonder Tongue Laboratories sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22024-06-303.3%
Q32024-09-306.9%
Q42024-12-310.6%
Q12025-03-310.2%
Blonder Tongue Laboratories annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20212021-12-31USD 0.01N/A
20222022-12-31USD -0.22N/A
20232023-12-31USD -0.15-31.2%
20242024-12-31USD -0.09-42.9%
Blonder Tongue Laboratories sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22024-06-3057.5%
Q32024-09-30-333.8%
Q42024-12-31-13.2%
Q12025-03-3135.0%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2025YOY CHG

Revenue

$2.92M

+11.2%

Gross Profit

$1.01M

-2.0%

Gross Margin

34.50%

N/A

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

N/A

N/A

Employees

67

N/A

Net Income

-$314.00K

-30.8%

EBITDA

$124.00K

-36.1%

Quarterly Fundamentals

Name
Q1 2025YOY CHG

Total Cash

$93.00K

+158.3%

Total Debt

$8.17M

-9.8%

Accounts Receivable

$1.66M

+7.5%

Inventory

$1.95M

-37.3%

Long Term Debt

$4.72M

-10.6%

Short Term Debt

$3.45M

-8.8%

Return on Assets

-13.24%

N/A

Return on Invested Capital

-21.96%

N/A

Free Cash Flow

$95.00K

-22.8%

Operating Cash Flow

$177.00K

+39.4%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
WGNRWegener Corporation
$0.01+2.50%
VRTCVeritec, Inc.
$0.00+0.00%
UBMRFUrbanimmersive Inc.
$0.00+0.00%
DLTIDLT Resolution Inc.
$0.70+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
SQQQProShares Trust - ProShares UltraPro Short Qqq
$41.43-0.05%
NVDANvidia
$206.64+0.03%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$7.81+0.07%
INTCIntel
$91.00+0.01%

Questions About BDRL

What is the current price of Blonder Tongue Laboratories?

Blonder Tongue Laboratories is trading at N/A per share.

What is the 52-week range for Blonder Tongue Laboratories?

Over the past 52 weeks, Blonder Tongue Laboratories has traded between N/A and N/A.

How much debt does Blonder Tongue Laboratories have?

As of the most recent reporting period, Blonder Tongue Laboratories reported total debt of $8.17M.

How much cash does Blonder Tongue Laboratories have on hand?

Blonder Tongue Laboratories reported $93.00K in cash and cash equivalents in its most recent financial results.

What is Blonder Tongue Laboratories’s dividend yield?

Blonder Tongue Laboratories does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services